update

PPD launches CRA apprenticeship program

By Melissa Fassbender contact

- Last updated on GMT

PPD launches CRA apprenticeship program
PPD is offering "on-the-job" training through a new, competency-based clinical research associate (CRA) apprenticeship program.

The program is targeted to military veterans and military service members with medical backgrounds transitioning to the civilian workforce.

According to Pharmaceutical Product Development, LLC (PPD), the program is the first CRA apprenticeship program registered with the US Department of Labor.

The twelve-month program will begin in the first quarter of this year at sites in North Carolina, California, and Texas.

The competency-based program​ provides training through the PPD's CRA academy and exposes participants to three clinical roles.

As Outsourcing-Pharma.com previously​ reported, competence and staff engagement have led to high turnover rates among clinical research associates. According to one report, US turnover in clinical monitoring reached​ 25.1% in 2015.

PPD’s application to make the CRA roll a recognized occupation for registered apprenticeship programs was approved by NCWorks, the North Carolina approving agency for the US Department of Labor, and the Office of Apprenticeship in California and in Texas.

The global contract research organization's (CRO) will be responsible for the coordination, administrative processes, and all programming aspects of the apprenticeship program.

"The quality of training in the military is very strong. Combined with discipline and process focus, military veterans with medical experience are an excellent fit for CROs​," Ed Murray, executive vice president and chief human resource officer for PPD, told Outsourcing-Pharma.com. 

"Creating this apprenticeship will increase the pipeline of successful professionals in the CRA talent pool as PPD continues its focus on building industry-leading talent and on aligning with our clients’ important work of bringing life-changing therapies to market​."

(Feature image: iStock/kunertus)

Related news

Show more

Related products

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers